BioSpace News Archive

Promaxo, Inc. (“Promaxo” or the “Company”), a medical imaging, robotics, and AI technology company, today announced Amit Vohra, Chief Executive Officer, will participate at the Piper Sandler 33rd Annual Virtual Healthcare Conference from November 22 to December 2, 2021.

Geron Corporation, a late-stage biopharmaceutical company focused on the development and commercialization of treatments for hematologic malignancies, summarized key highlights from its Investor Event held on November 9.

One BioMed, a company focused on advancing human health through innovation, announced the launch of their Xceler8™ Platform for high-yield extraction and purification of nucleic acids from biological samples.

Chinook Therapeutics, Inc. announced the pricing of its upsized underwritten public offering of 7,828,572 shares of its common stock at a price to the public of $14.00 per share.

AnPac Bio-Medical Science Co., Ltd., a biotechnology company with operations in China and the United States focusing on early cancer screening and detection, announced the pricing of an underwritten public offering of 1,301,928 of its American Depositary Shares at a public offering price of $2.22 per share, for gross proceeds to the Company of approximately $2.9 million, before deducting the underwriting discount and other offering expenses payable by the Company.

Ascletis Pharma Inc. (HKEX: 1672) today announces the approval of the Phase II clinical trial of ASC22 (Envafolimab) by China National Medical Products Administration (NMPA) for the proposed new indication of immune restoration/functional cure of human immunodeficiency virus 1 (HIV-1) infected patients.

Avenue Therapeutics, Inc., a company focused on the development of intravenous tramadol for the U.S. market, announced the pricing of an underwritten public offering with gross proceeds to the Company expected to be approximately $2.6 million, before deducting underwriting discounts and commissions and other estimated expenses payable by the Company.

Agiliti Inc. (NYSE: AGTI) (“Agiliti”), a nationwide provider of healthcare technology management and service solutions to the United States healthcare industry, today announced its financial results for the quarter ended September 30, 2021, and raised its full-year guidance for 2021.

Streamline Health Solutions, Inc. (Nasdaq: STRM), provider of the eValuator™ Revenue Integrity Program to help healthcare providers proactively address revenue leakage and improve financial performance, has been invited to participate in the 12th Annual Craig-Hallum Alpha Select Conference, which is being held virtually on Tuesday, November 16, 2021.

Cara Therapeutics, Inc., a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, announced that Christopher Posner, President and Chief Executive Officer, will participate in the following upcoming investor conferences in November: